How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator

Verfasser / Beitragende:
[G. Gandaglia, RCN van den Bergh, D. Tilki, N. Fossati, P. Ost, C.I. Surcel, P. Sooriakumaran, I. Tsaur, M. Valerio, A. Kretschmer, E. Zaffuto, L. Salomon, F. Montorsi, M. Graefen, H. van der Poel, A. de la Taille, A. Briganti, G. Ploussard]
Ort, Verlag, Jahr:
2018
Enthalten in:
BJU international, 122/5(2018-11), 823-830
Format:
Artikel (online)
ID: 549334386